StemCell Therapy

A European company is pioneering a bloodless way for people with diabetes to monitor their glucose levels.

Why it matters: More than 5% of the global population is affected by diabetes, and the number is set to keep rising. A more seamless monitoring system would make it easier for people with diabetes to manage their conditions and avoid disastrous health outcomes.

How it works: DiaMonTech is developing machines that use lasers and an optical lens to read glucose levels through the skin photothermally.

Background: People with diabetes suffer from problems managing blood sugar levels that stem from their inability or inefficiency of their bodies to produce the glucose-regulating hormone insulin.

What to watch: DiaMonTech has developed a lab-based version of its system that has been certified for medical use in clinics in Europe, and is working on a hand-held device for personal use that Lubinski believes could be ready by 2022.

Read more here:
Diabetes monitoring without the needle - Axios

This entry was posted on February 14, 2021 at 7:20 pm and is filed under Diabetes. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |